Study Groups for Coronavirus Pandemic

N/A

Waitlist Available

Research Sponsored by 3EO Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1-16 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a new rapid COVID-19 detection method called the 3EO Health COVID-19 Test. It targets people at medical facilities to see how well it works. The test uses a nasal swab and a special device to quickly find the virus's genetic material.

Eligible Conditions

Coronavirus Pandemic

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1-16 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1-16 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-16 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Correlation of the 3EO Health SARS-CoV-2 standard of care (PCR) Zymo rRT-PCR results of the anterior nare sample.

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Study GroupsExperimental Treatment1 Intervention

Positives: Symptomatic vs. Asymptomatic Negatives: Symptomatic vs. Asymptomatic Each broken down by age groups: 2-14 years old 15-24 years old 25-64 years old 65+ years old

Do I qualify?Apply below to find out